apl. Prof. Dr. Clemens Neufert

Medizinische Fakultät

Hobit- and Blimp-1-driven CD4(+) tissue-resident memory T cells control chronic intestinal inflammation (2019) Zundler S, Becker E, Spocinska M, Slawik M, Parga-Vidal L, Stark R, Wiendl M, et al. Journal article Cellular Mechanisms of Etrolizumab Treatment in Inflammatory Bowel Disease (2019) Lichnog C, Klabunde S, Becker E, Fuh F, Tripal P, Atreya R, Klenske E, et al. Journal article Rationale for IL-36 receptor antibodies in ulcerative colitis (2019) Neufert C, Neurath M, Atreya R Journal article STAT3 activation through IL-6/IL-11 in cancer-associated fibroblasts promotes colorectal tumour development and correlates with poor prognosis (2019) Heichler C, Scheibe K, Schmied A, Geppert CI, Schmid B, Wirtz S, Thoma OM, et al. Journal article Resolution of Crohn’s disease (2019) Schmitt H, Neufert C, Neurath M, Atreya R Journal article, Review article Non-classical monocyte homing to the gut via α4β7 integrin mediates macrophage-dependent intestinal wound healing (2019) Schleier L, Wiendl M, Heidbreder K, Binder MT, Atreya R, Rath T, Becker E, et al. Journal article Comparison of Hemospray® and Endoclot™ for the treatment of gastrointestinal bleeding (2019) Vitali F, Naegel A, Atreya R, Zopf S, Neufert C, Neurath M, Rath T, Siebler J Journal article Dynamic Adhesion Assay for the Functional Analysis of Anti-adhesion Therapies in Inflammatory Bowel Disease (2018) Becker E, Schramm S, Binder MT, Allner C, Wiendl M, Neufert C, Atreya I, et al. Journal article Similar Inhibition of Dynamic Adhesion of Lymphocytes From IBD Patients to MAdCAM-1 by Vedolizumab and Etrolizumab-s (2018) Binder MT, Becker E, Wiendl M, Schleier L, Fuchs F, Leppkes M, Atreya R, et al. Journal article Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice with Chronic Intestinal Inflammation (2018) Scheibe K, Kersten C, Schmied A, Vieth M, Primbs T, Carlé BE, Knieling F, et al. Journal article